Block ionomer complex (BIC)-siRNA interactions and effectiveness in cell transfection are reported. Aqueous RAFT polymerization was used to prepare a series of hydrophilic-blockcationic copolymers in which the cationic block statistically incorporates increasing amounts of neutral, hydrophilic monomer such that the number of cationic groups remains unchanged but the cationic charge density is diluted along the polymer backbone. Reduced charge density decreases the electrostatic binding strength between copolymers and siRNA with the goal of improving siRNA release after targeted cellular delivery. However, lower binding strength resulted in decreased transfection and RNA interference pathway activation, leading to reduced gene knockdown. Enzymatic siRNA degradation studies with BICs indicated lowered binding strength increases susceptibility to RNases, which is the likely cause for poor gene knockdown.
Introduction
RNA interference (RNAi) triggers post-transcriptional gene suppression via sequencespecific recognition and destruction of cellular transcripts. 1 "Gene knockdown" is achieved through delivery of synthetic small interfering RNA (siRNA), which can be designed to target the gene of interest, [2] [3] [4] [5] making RNAi appealing for gene therapeutics. However, RNA delivery vehicles must overcome a number of barriers, including target specificity and vehicle cytotoxocity. 5 phosphodiester backbone to form interpolyelectrolyte complexes (IPECs). 6, 7 Such IPECs are often characterized by the molar ratio of cationic functionalities (e.g. amines) to phosphodiester units, termed the nitrogen-to-phosphate ratio (N:P). Non-stoichiometric IPECs from cationic homopolymers have been extensively studied and provide enhanced protection from enzymatic degradation while maintaining complex hydrophilicity. 3, 8 However, the excess charges required to maintain solubility result in adverse effects: negatively-charged complexes (N:P < 1) suffer from decreased transfection due to electrostatic repulsion at the negatively-charged cellular membrane, and positively-charged complexes (N:P > 1) result in increased cytotoxity and opsonization within the blood stream, leading to higher immune response. 6, [9] [10] [11] Block copolymers consisting of a cationic block and a non-ionic, hydrophilic block can form stoichiometric, neutrally charged IPECs with RNAs while maintaining complex hydrophilicity. These so-called block ionomer complexes (BICs) exhibit both decreased cytotoxicity and enhanced stability, 7, 12 and incorporation of cellular targeting moieties within their hydrophilic, corona-forming blocks results in cellspecific siRNA delivery. 8, 13 Our research group has maintained a strong interest in the rational design and synthesis of drug delivery systems utilizing aqueous RAFT (aRAFT) polymerization targeting controlled, tailored (co)polymers for stimuli-responsive micelles, [14] [15] [16] theranostics, 17 peptide mimics, 18 modular copolymers, 19, 20 and vehicles for endosomal escape. 21 Our most recent efforts have focused on the development of siRNA-containing BICs for cell-specific delivery as well as determining the effect of aRAFT copolymer architecture on siRNA delivery efficacy. Previously, we demonstrated targeted cellular delivery and subsequent gene knockdown using BICs formed between siRNA and hydrophilic-block-cationic copolymers. 13 Furthermore, we observed a correlation between cationic block length and siRNA stabilization as well as gene knockdown efficacy: longer cationic block lengths resulted in increasingly enhanced siRNA stability as well as longer time periods required to achieve maximum gene knockdown in vitro. 22 We attributed delayed gene suppression to slow release of the siRNA from the complexes, presumably via macromolecular exchange. This correlates well with other groups' findings that enhanced complexation and stability in plasmid DNA (pDNA) delivery result in inefficient DNA release, indicating that intermediate binding and stability is desireable. [23] [24] [25] Such intermediacy is likely achievable via alteration of the cationic charge density. Indeed, IPECs formed from polymers with varying degrees of cationic quaternization yield higher pDNA transfection efficiency and expression at moderate charge densities as compared to linear polycations. 24, 25 However, variable charge density has not been studied in BICs, specifically those containing siRNA.
In this study, we report the synthesis of a series of hydrophilic-block-cationic copolymers via aRAFT polymerization in which the cationic block statistically incorporates increasing amounts of neutral, hydrophilic monomer such that the number of cationic groups remains unchanged but the cationic charge density is diluted along the polymer backbone. These polymers were subsequently complexed with siRNA and siRNA analogs. To our knowledge, this is the first study directed toward elucidating the effect of cationic block charge density on BIC binding strength/stability and siRNA delivery. siRNA stability and BIC binding strength were evaluated utilizing solution differential scanning calorimetry (DSC) and potentiometric titration respectively, and cellular siRNA delivery experiments were performed to correlate those results with gene knockdown efficacy. Herein, we demonstrate reduced siRNA stability, binding strength, and gene knockdown with decreasing cationic block charge density. We correlate these trends to reduced siRNA delivery and uptake within the RNAi pathway, which suggests greater siRNA vulnerability to enzymatic degradation. Indeed, we confirm higher rates of enzymatic hydrolysis with reduced cationic charge density by establishing RNase degradation kinetic profiles. We conclude that while reduced binding strength results in more rapid siRNA release via macromolecular exchange, such facile exchange increases the likelihood of degradation prior to activation of the RNAi pathway.
Results and Discussion

Synthesis of hydrophilic-block-cationic copolymers with varying cationic block charge density
Based upon our previous observation that decreasing cationic block length reduces the time required to achieve maximum gene knockdown, 22 we reasoned that reduced cationic block charge density should decrease BIC binding strength, facilitating the release of siRNA from the complexes via more rapid macromolecular exchange.
We therefore synthesized hydrophilic-block-cationic copolymers with varying cationic block charge density (Scheme 1). The first step was accomplished using aRAFT to prepare a statistical macroCTA consisting of an initial monomer feed ratio of 95 mol % N-(2hydroxypropyl)methacrylamide (HPMA) and 5 mol % N-(3-aminopropyl)methacrylamide (APMA) in 1 M acetate buffer (pH = 4.5) at 70 °C using 4-cyano-4-[(ethylsulfanylthiocarbonyl)sulfanyl]pentanoic acid (CEP) as the CTA and 4,4'azobiscyanovaleric acid (V-501) as the initiator. HPMA contributes non-ionic hydrophilicity to the copolymer, and is known to be non-immunogenic, 26 promoting greater biocompatibility. Incorporation of the primary amine functionality of APMA provides a convenient handle for the conjugation of the cellular-targeting moiety folic acid. 1 H NMR analysis revealed a final copolymer composition of 97 mol % HPMA and 3 mol % APMA, which closely matches the monomer feed ratio.
The resulting poly(HPMA 226 -stat-APMA 7 ) macroCTA was subsequently subjected to a series of chain extensions with both HPMA and N- [3-(dimethylamino) propyl]methacrylamide (DMAPMA), targeting DMAPMA monomer molar feeds, and thus charge densities, of 100% (P100), 75% (P75), 50% (P50), 25% (P25), and 0% (P0) ‡. The tertiary amines of DMAPMA provide cationic sites under physiological conditions (pH = ~7.4) for complexation with the negatively-charged siRNA backbone. Additionally, the statistical incorporation of HPMA within the cationic block allows for increased spacing of the cationic groups, and thus lower charge density, along the polymer backbone while minimizing inter-and intramolecular hydrophobic interactions of the copolymers. ASEC-MALLS chromatograms for the macroCTA and the chain extensions are shown in Figure 1 , and the relevant polymer characterization data are summarized in Table  1 . Shifts to lower elution volume while maintaining low dispersities (Ð < 1.2) indicate successful chain extension, and 1 H NMR analysis revealed block compositions (block A: HPMA-stat-APMA; block B: HPMA-stat-DMAPMA) closely matching the monomer feed ratios. Cationic block charge densities are reported as molar percentages of DMAPMA within block B.
The post-polymerization modification of APMA units with folic acid, which our group has previously demonstrated to function well as a cell-specific targeting moiety, 13 was monitored via UV-Vis spectroscopy (ESI † Figure S2 ). Based on an average extinction coefficient for free folic acid at pH = 7.4, approximately 4 of 7 possible APMA units per polymer were successfully labelled. This extent of folic acid conjugation, combined with low APMA molar content, resulted in hydrophilic-block-cationic copolymers capable of electrostatically complexing with oligonucleotides through the DMAPMA tertiary amines of cationic block B, while the hydrophilic, cellular-targeting block A maintains BIC solubility. Thus, oligonucleotide complexation with these well-defined hydrophilic-block-cationic copolymers with varying charge density allows for correlation of cationic block charge density to BIC complexation strength and in vitro gene knockdown.
Hydrophilic-block-cationic copolymers with varying charge density form stable, neutrallycharged complexes
Having successfully synthesized a series of hydrophilic-block-cationic copolymers with varying cationic block charge density, we used dynamic light scattering (DLS) and ζpotential measurements to confirm their ability to complex siRNA while maintaining charge neutrality at N:P = 1. Table 2 presents the hydrodynamic radius (R h ) and ζ-potential of each copolymer-siRNA complex. The siRNA-containing BICs exhibited an average R h of 9.6 nm, a value consistent with previously reported complexes of similar cationic content. 13 Copolymer solutions free of siRNA did not exhibit any particles visible by DLS (data not shown), indicating that the observed hydrodynamic radii indeed result from complex formation rather than copolymer aggregation. The near-zero ζ-potential values confirm complex charge neutrality, targeted for preventing cytotoxicity. The amount of polymercomplexed siRNA was quantified using the Agilent Bioanalyzer platform (electropherograms in ESI † Figure S6 ), and copolymers P25-P100 complexed approximately 76% of available siRNA, which is comparable to our previous report. 27
Reduced cationic block charge density decreases oligonucleotide stabilization
Relative oligonucleotide stability can be determined by elucidating the melting temperature (T m ), i.e. the temperature at which the double-stranded duplex separates into its singlestranded components. An increase in T m , which is manifested as an endotherm maximum in the DSC thermogram, is indicative of increased duplex stability. 28 Previous work in our laboratories used dsDNA as an analog to siRNA in order to ascertain the effect of cationic block length of the copolymer on oligonucleotide stability. 22 In the present study, we used samples P0-P100 to prepare BICs with dsDNA, and the respective DSC thermograms are shown in Figure 2 . Complexation results in increased T m over that of free dsDNA (T m = 54.4 °C). 22 Generally, T m decreases with decreasing cationic block charge density (P75, 83.3 °C > P50, 81.3 °C > P25, 75.0 °C). Although P100 has a continuous (i.e. no neutral comonomer) cationic block, its actual number of charges (14 DMAPMA units) is lower than for polymers P25-P75 (~20 DMAPMA units), resulting in a T m = 81.0 °C. However, BICs formed with previously reported (HPMA 171 -stat-APMA 13 )block-DMAPMA 27 (P2), which has a longer continuous cationic block, exhibit a dsDNA T m value of 88.4 °C. 22 Therefore, we may conclude that the enhanced oligonucleotide stability afforded by complexation decreases as cationic block charge density decreases.
Reduced cationic block charge density reduces complex binding strength
Having confirmed that reduced charge density diminishes the oligonucleotide-stabilizing effect of complexation, we next sought to demonstrate that it similarly reduces BIC binding strength as characterized by the free energy of complex formation. The cationic nature of weak polyelectrolytes, such as those containing DMAPMA, is due to the pH-dependent protonation of the amine functionalities and thus can be monitored via potentiometric acidbase titration. From the potentiometric titrations of a polyelectrolyte and its corresponding IPEC, one can obtain the degrees of protonation (α, fraction of protonated amines) and complexation (θ, fraction of ionic complex pairs out of total possible pairs) respectively. Kabanov and co-workers 7 have demonstrated that for IPECs consisting of a weak polyelectrolyte (e.g. PDMAPMA) and a strong polyelectrolyte (e.g. siRNA), all of the protonated units of the weak polycation will form ionic pairs with a strong polyanion functionality, i.e. α = θ. Due to the cooperativity of IPEC formation, a shift (ΔpH(α)) occurs in the θ vs. pH curve of an IPEC relative to the α vs. pH curve of the corresponding free polycation ( Figure 3A ). The free energy of complex formation (ΔG total ) as a function of α, where α = α 1 (= θ 1 ), is given by the following: 7 Evaluation of the binding strength of oligonucleotide-containing BICs by potentiometric titration is complicated by the pH-dependent protonation of DNA and RNA bases. Thus, in this study we have adopted an approach similar to that of Lee et al. 29 who used polystyrene sulfonate (PSS) as a strong polyanion analog that does not affect the titration curve over the pH range investigated. We selected PSS with low molecular weight (M n = 16 kDa, DP ≈ 69) such that the number of anionic charges is similar to that of duplex siRNA (59 nucleotides). Figure 3 depicts the αand θ vs. pH curves for P0-P100 and lists the free energies of complexation for copolymer-PSS BICs. In general, the magnitude of free energy decreases with decreasing cationic block charge density (P75, −3.28 kJ/mol; P50, −2.42 kJ/mol; P25, −1.35 kJ/mol). Consistent with the DSC experiments in the previous section, despite being a continuous cationic block, the fewer number of charges in P100 relative to P25-P75 results in a lower binding strength with a ΔG total value of −2.61 kJ/mol. However, titration of (HPMA 171 -stat-APMA 13 )-block-DMAPMA 27 (P2) 22 with a longer continuous cationic block length yields a ΔG total value of −4.4 kJ/mol. Thus, we may conclude that binding strength decreases with reduced cationic charge density.
Reduced charge density diminishes gene knockdown efficacy
Based on the trends of decreasing oligonucleotide stabilization and BIC binding strength with decreasing cationic block charge density, one would expect that decreased charge density would lead to greater bioavailability of the siRNA within cells via more rapid release and, therefore, enhanced gene knockdown. However, experimental results were opposite of this expectation. Figure 4A depicts the relative survivin mRNA levels 24 hours after treatment with copolymer-siRNA BICs. P100 and P75 copolymers resulted in 2-and 3-fold mRNA expression, respectively, relative to the Lipofectamine positive control. However, polymers with charge density less than 75% exhibited no decrease in survivin mRNA levels relative to the untreated negative control. Although diminished gene knockdown with reduced charge density is the opposite of the expected trend, these results are likely the result of more rapid macromolecular exchange due to reduced binding strength: rapid exchange with extra-and intracellular proteins results in reduced cellular delivery of siRNA and increased susceptibility to degradation by RNases (vide infra).
Cellular delivery and RNAi pathway activation decrease with reduced cationic block charge density
To determine the relative cellular loading of siRNA by each polymer, cells were treated with copolymer-(fluorescently-labelled siRNA) BICs and were subsequently imaged via confocal fluorescence microscopy (images in ESI † Figure S5 ). The corrected total fluorescence (CTF) of representative areas for each treated cell culture is depicted in Figure 4B , and decreasing cellular siRNA content was observed with decreasing cationic block charge density. Furthermore, statistical analysis of CTF revealed a significant decrease in siRNA content between P75 and P50, which corresponds well to lack of gene knockdown for copolymers with charge density < 75%. Because siRNA release must result from a macromolecular exchange reaction rather than spontaneous dissociation, 7 the decreased cellular delivery must be the result of exchange reactions with biomacromolecules in the extracellular media. However, P50 and P25 successfully delivered moderate amounts of siRNA, yet no gene knockdown was observed, suggesting reduced siRNA participation in the RNAi pathway.
Quantification of protein-bound siRNA within the cells serves as an indication of the level of RNAi activity. Because the threshold in cationic block charge density required for successful gene knockdown lies between P75 and P50, these copolymers were used to deliver radiolabelled siRNA, and the treated cells were subjected to cellular fractionation via sucrose density gradients. The fractions were then subjected to PAGE, followed by electroblotting to quantify the relative amounts of radio-labelled siRNA in each, depicted in Figure 4C . Higher fraction numbers correspond to increased gradient density; therefore, farther migration of siRNA into the heavier fractions is indicative of siRNA-protein complexes (i.e. siRNA entry into the RNAi pathway). siRNA levels have been normalized to fraction 1 (i.e. protein-free siRNA) for each cell culture. P75 complexes resulted in a greater amount of proteincomplexed siRNA relative to its protein-free siRNA than did P50, indicating that, in addition to increased cellular siRNA concentration, P75 complexes resulted in a greater percentage of that siRNA participating in RNAi. Therefore, as cationic block charge density decreases, less siRNA is trafficked into the cells, and even less RNAi activation is achieved.
When taken in conjunction, the fluorescence microscopy and cell fractionation results suggest that instead of increasing siRNA bioavailability, decreasing cationic block charge density leaves the siRNA more vulnerable to enzymatic degradation by RNases within the cell culture media and within the cells themselves. Reineke and coworkers 30 reported similar results utilizing hydrophilic-stat-cationic and hydrophilic-block-cationic copolymers to deliver luciferase-expressing plasmid DNA (pDNA): statistical copolymerization of their tertiary amine-containing monomer resulted in decreased luciferase expression relative to the block copolymer. The authors suggested that statistical copolymerization may have resulted in more rapid complex dissociation and thus inefficient trafficking of the pDNA to the nucleus. Our demonstration of decreased BIC binding strength with lower charge density, along with diminishing siRNA delivery and RNAi activation, corroborates their conclusion: weaker binding likely results in more rapid macromolecular exchange with cellular proteins like RNases.
Enzymatic degradation rates increase as cationic block charge density decreases
Although siRNA degradation within cells cannot be directly observed, circular dichroism (CD) spectroscopy can be used to monitor the degradation kinetics of siRNA by RNases in vitro. The characteristic CD spectrum peaks of siRNA result from its secondary structure, 31 and thus we monitored the molar ellipticity at 212 nm ([θ] 212 ) as the siRNA was hydrolyzed along its phosphodiester backbone by Riboshredder RNase blend ( Figure 5A ). Figure 5B depicts normalized [θ] 212 of siRNA and copolymer-siRNA complexes as a function of time. Based upon the gene knockdown, cellular loading, and cell fractionation experiments, we expected to see an increase in the rate of degradation with decreasing cationic block charge density. Indeed the decay rate of [θ] 212 increases from P100 to P0, indicating that decreased charge density does result in decreased protection from enzymatic degradation. This notion is in good agreement with the decreased oligonucleotide stabilization and binding strength, determined via solution DSC and potentiometric titration respectively, as a function of decreasing charge density.
Conclusions
The aRAFT polymerization of hydrophilic-block-cationic copolymers with varying cationic block charge densities and their subsequent complexation with siRNA and siRNA analogs has been demonstrated. Reduced charge density in these BICs resulted in lower oligonucleotide stabilization and binding strength, characteristics that predict more rapid siRNA release and thus enhanced gene suppression. However, decreased cellular transfection and RNAi activation, which resulted in decreased gene knockdown, indicate that decreased binding strength afforded by reduced charge density promotes greater susceptibility to enzymatic degradation. Indeed the higher rate of in vitro RNase degradation with decreasing charge density supports this notion. Components of the RNAi pathway likely have a higher affinity for siRNA than do other RNA-binding proteins (e.g. RNases). Thus, they likely are able to extricate siRNAs from higher charge density copolymers, whereas less specific RNases cannot.
These results indicate that for hydrophilic-block-cationic copolymers with relatively few charges (i.e. ~20 DMAPMA units), siRNA delivery is most effective utilizing a fully charged cationic block without non-ionic comonomer. However, it is worth noting that decreasing cationic block charge density diminishes copolymer cytotoxicity (ESI † Figure  S6 ). Thus, application of variable charge density to block copolymers with a greater number of DMAPMA units should improve polymer biocompatibility while providing sufficient number of cations to maintain siRNA protection. The effect of cationic block charge density in copolymers with greater cationic content is the subject of ongoing investigation.
Experimental Materials
All reagents were purchased from Sigma and used as received unless otherwise noted. 4,4'-Azobiscyanovaleric acid (V-501) was purchased from Wako and was recrystallized twice from methanol. Azobisisobutyronitrile (AIBN) was recrystallized from methanol. N-(3aminopropyl)methacrylamide hydrochloride (APMA) was purchased from Polysciences. N-[3-(dimethylamino)propyl]methacrylamide (DMAPMA) and triethylamine (TEA) were distilled prior to use. 4-cyano-4-[(ethylsulfanylthiocarbonyl)sulfanyl]pentanoic acid (CEP), 32 di-N-hydroxysuccinimide-activated folic acid (diNHS-FA), 13 and N-(2hydroxypropyl)methacrylamide (HPMA) 33 were synthesized according to literature procedures. Sodium polystyrene sulfonate (PSS) (Mn = 14.2 kDa, Ð = 1.13) was purchased from Scientific Polymer Products. HPLC purified oligonucleotides (siRNA against human survivin; unlabelled and AlexaFluor594-labeled, pre-diced siRNA; and oligomeric dsDNA) were purchased from Integrated DNA Technologies, Inc. The siRNA sequences targeting human survivin are as follows: Sense strand 5′-AGCCCUUUCUCAAGGACCACCGCAUCU-3′ and the antisense strand 3′-UUUCGGGAAAGAGUUCCUGGUGGCGUAGAGGA-5′. The pre-diced siRNA sequences are as follows: Sense strand 5'-GCUGGACUCCUUCAUCAACdTdT-3' and the antisense strand 3'-dTdTCGACCUGAGGAAGUAGUUG-5' ("dT" indicates deoxythiamine DNA base). The dsDNA sequences are as follows: Sense strand 5'-AGATGTGCAATTTTGCTACCGCATCT-3' and the antisense strand 5'-AGGAGATGCGGTAGCAAAAGTTGCACATCTTT-3'. Oligonucelotides (siRNA and dsDNA) were heated at 95 °C for 10 min and were allowed to slowly cool to room temperature prior to use. Concentrations of oligonucleotide (siRNA and dsDNA) are reported as duplex concentrations unless otherwise noted. Gibco ® RPMI 1640 cell culture media (with and without folic acid) and fetal bovine serum (FBS) were purchased from Life Technologies Corporation. KB cells were purchased from ATCC. For reactions requiring nitrogen, ultrahigh purity nitrogen (purity ≥ 99.998%) was used. Spectra/Por ® regenerated cellulose dialysis membranes (Spectrum Laboratories, Inc) with a molecular weight cut-off of 12-14 kDa were used for dialysis.
Polymer Synthesis
Synthesis of poly(HPMA-stat-APMA) macroCTA-The macro chain transfer agent (macroCTA) was prepared employing V-501 as the primary radical source and CEP as the chain transfer agent at 70 °C. HPMA (12.61 g, 95.1 mmol) and APMA (894 mg, 5.0 mmol) were added to a 250 ml round-bottomed flask and dissolved in 1 M acetate buffer (pH = 4.5) with a final volume of 100 ml ([M] 0 = 1 M). The initial feed composition was 95 mol % HPMA and 5 mol % APMA. The round-bottomed flask was septum-sealed and purged with nitrogen for 1 hour prior to polymerization. The macroCTA was prepared with a [M] 0 /[CTA] ratio = 400 while the [CTA]/[I] ratio was kept at 5, and the reaction was allowed to proceed for 5 h. The polymerization was quenched by rapid cooling in liquid nitrogen followed by exposure to air. The macroCTA was isolated by dialysis (pH = 3-4) at 4 °C and recovered by lyophilization. [(HPMA-stat-APMA)-block-(HPMA-stat-DMAPMA) ] copolymers (P100, P75, P50, P25, and P0) Block copolymer end-groups were removed via a standard literature procedure. 34 A typical reaction is as follows: poly[(HPMA 226 -stat-APMA 7 )-block-DMAPMA 14 ] (P100) (575 mg, 14.3 µmol) was added to a 25 ml round-bottomed flask and dissolved in 6 ml of DMF. AIBN (70.4 mg, 0.429 mmol) was then added to the flask resulting in an AIBN/copolymer ratio of 30:1. The solution was then septum-sealed, purged with nitrogen for 1 h, and allowed to react at 70 °C for 4 h. The resulting copolymer was precipitated from DMF into cold anhydrous diethyl ether three times.
Synthesis of poly
Copolymer functionalization with folic acid
DiNHS-FA was prepared following a slightly modified literature prcedure. 13 Briefly, folic acid (1.00 g, 2.3 mmol), NHS (1.30 g, 11.3 mmol), DCC (4.68 g, 22.7 mmol), and DMAP (277.5 mg, 2.3 mmol) were dissolved in 15 ml DMSO and stirred in the dark at room temperature for 24 h. The dicyclohexylurea precipitate was filtered off and the resulting solution was used without further purification.
The aforementioned diNHS-FA solution was then used to label the primary amine moieties of the APMA units in the chain-terminated block copolymers. A typical reaction is as follows: 49.5 mg (1.23 µmol) P100 was dissolved in 1 ml DMSO along with 5 µL TEA to serve as a catalyst. 1.53 ml of the diNHS-FA solution was added dropwise and the resulting solution was stirred in the dark at room temperature for 48 h. The reaction was quenched by the addition of excess ammonium hydroxide (100% by volume), and this reaction was carried out for 24 h. The resulting solution was then dialyzed against 0.6 M NaCl for 24 h,
Fluorescence Microscopy
24 hours prior to treatment, the KB cell medium was replaced with folic acid-free RPMI 1640 supplemented with 10% FBS. Cells (200,000 cells/mL, 2 mL) were seeded on cover glasses in a 6 well plate (Corning Inc.). Cells were treated with 500 µL of a polymer-siRNA (siRNA tagged with AlexaFluor594) complex solution. Lipofectamine 2000 (Invitrogen) was used as the positive control, and the Lipofectamine-siRNA complexes were prepared according to manufacturer protocol. The final siRNA concentration delivered was maintained at 100 nM. After 24 hours, the cells were fixed with 4% formaldehyde and washed with PBS prior to imaging. The cells were then stained with 12 µL of 4',6diamidino-2-phenylindole (DAPI) mounting medium. The cover glasses were then placed on precleaned microscope slides for analysis. Fluorescence cell images were taken using a Zeiss LSM 510 scanning confocal microscope and processed with manufacturer software. Multiple fields were examined for each sample to ensure uniform distribution of complexes throughout. Representative areas were selected in quadruplicate, the fluorescence intensities were determined in ImageJ, and the corrected total fluorescence (CTF) of each area was calculated according to the relation Statistical variance between samples was calculated via a one-way ANOVA with Tukey analysis in Minitab (version 17.1.0).
Cell Fractionation
Prior to cell treatment, the siRNA 5'-phosphate was substituted with 32 P-containing phosphate using polynucleotide Kinase (Fisher) and γ-32 P ATP (6000 Ci/mmol) as the source of isotope. The KB cell medium was replaced with folic acid-free RPMI 1640 supplemented with 10% FBS. Cells (200,000 cells/mL, 2 mL) were seeded in a 6 well plate (Corning Inc.). After 24 hours, cells were treated with 500 µL of a radio-labelled polymer-siRNA complex solution. Lipofectamine 2000 (Invitrogen) was used as the positive control, and the Lipofectamine-siRNA complexes were prepared according to manufacturer protocol. The final siRNA concentration delivered was maintained at 100 nM. After 24 hours, the cell media was removed, and the cells were lysed with 1 mL lysing buffer (150 mM HEPES, pH = 8.0; 0.25% Triton X; 10% glycerol).
Linear sucrose gradients (10%-50% w/w in 25 mM Tris-HCl (pH = 7.5), 25 mM NaCl, 5 mM MgCl 2 ) were prepared by carefully layering 400 µL of each sucrose solution in a Beckman 13 × 51 mm thickwall polycarbonate tube at 0 °C. Total cell lysates were carefully overlaid onto the gradients and centrifuged at 36,000 rpm for 2 hrs at 4 °C in a SW 55 Ti rotor. Gradient fractions were then collected in 300 µL increments, and total RNA was precipitated into 1 ml of isopropanol, employing 1 µL glycogen solution as a co-precipitant. After centrifugation, the supernatant was removed, and the precipitants were suspended in 2X RNA loading buffer from Ambion. RNA was separated on a 12% acrylamide gel containing 8 M urea, and visualized with ethidium bromide staining on a BioRad ChemiDoc MP. The gel was then electroblotted and crosslinked. The radio-labelled siRNA was imaged using a GE Healthcare Life Sciences Typhoon FLA-7000. The relative amount of siRNA was quantified in bands corresponding to both free siRNA and that loaded in protein complexes using densitometry software ImageQuant.
Copolymer Cytotoxicity
The anti-proliferative activities of poly[(HPMA-stat-APMA)-block-(HPMA-stat-DMAPMA)] copolymers were determined following a standard literature procedure. 24 hours prior to treatment, the KB cell medium was replaced with folic acid-free RPMI 1640 supplemented with 10% FBS. Cells (200,000 cells/mL, 100 µL) were seeded in a 96 well plate (Corning Inc.). Cells were treated with 50 µL of a polymer stock solution at a polymer concentration equivalent to that used in the gene suppression studies. Cell proliferation was determined via a standard MTT assay (Vybrant MTT Cell Proliferation Assay Kit; Invitrogen). Cells were incubated for 48 h and 72 h before adding 10 µL of a 12 mM MTT reagent to each well. The cells were further incubated for an additional 4 h, followed by adding 100 µL of a SDS (10%)/HCl (0.01 M) solution to each well. The absorbance was then determined utilizing a Biotek Synergy2 MultiMode Microplate Reader. All studies were performed in triplicate. a Research Electro-Optics Model 31425 He-Ne laser operating at 35 mW. The angular dependence (60°-120° in 10° increments) of the autocorrelation function was determined with a Brookhaven Instruments BI-200SM goniometer with an Avalanche photodiode detector and TurboCorr autocorrelator. DLS measurements were carried out at a complex concentration (siRNA + block copolymer) of 1.0 mg/ml in phosphate buffer (10 mM P i , pH = 7.4) at 25 °C. The mutual diffusion coefficients (D m ) were determined from the relation in which Γ and q 2 represent the decay rate of the autocorrelation function and the square of the scalar magnitude of the scattering vector respectively. The hydrodynamic radius (R h ) was then calculated from the Stokes-Einstein equation:
Characterization
in which η is the solution viscosity, k B is Boltzmann's constant, and T is the temperature in K. Samples were vortexed to ensure homogeneity and equilibrated for 30 min at 25 °C prior to measurement. To remove dust, samples were passed through a 0.45 µm Millipore filter (PVDF) directly into the scattering cells. Measurements were performed in triplicate.
Zeta-potential measurements were carried out at a complex concentration of 1.0 mg/ml in phosphate buffer (10 mM P i , pH = 7.4) using a Malvern Zetasizer Nano ZEN3600. Samples were vortexed to ensure homogeneity and equilibrated for 30 min at 25 °C prior to measurement. To remove dust, samples were centrifuged at 14,000 RPM for 10 min. Measurements were performed in triplicate.
Quantification of polymer-complexed siRNA was achieved using the Agilent 2100 Bioanalyzer platform with the Small RNA kit following manufacturer protocol. Samples were prepared with [siRNA] = 100 nM, N:P = 1 in RNase-free water. Samples were vortexed to ensure homogeneity and equilibrated for 30 min at 25 °C prior to measurement. The free siRNA concentration was determined from the area of the peak at ~39 s using the companion software. Percent complexed siRNA was calculated as 1 -[siRNA 39s, complex ]/ [siRNA 39s, control ].
All calorimetric experiments were carried out using a Calorimetric Sciences Corporation Nano DSC-II solution differential scanning calorimeter (DSC). Sodium cacadylate buffer (10 mM, pH = 7.2) was used as the running buffer. dsDNA (analog for siRNA) concentration was maintained at 75 µM while copolymer concentrations were adjusted to maintain N:P = 1. CpCalc (Version 2.1, Calorimetric Sciences Corp.) was used to subtract buffer-buffer scans from buffer-sample scans.
Potentiometric titration experiments were carried out using a Metrohm 848 Titrino Plus autotitrator. Polymer samples were prepared in 5.0 ml of 18.2 MΩ diH 2 O and concentrations were adjusted to maintain a total amine concentration (i.e. DMAPMA unit concentration) of 1 mM. The pH of the solution was adjusted to 2.0 via the addition of 1 N HCl, followed by autotitration to pH = 12.0 with 0.05 N NaOH at 25 °C. For polymer-polystyrene sulfonate Samples not belonging to same letter grouping were found to have statistically significant variance via Tukey analysis. (C) Relative radio-labelled siRNA content after copolymer complex delivery and cell fractionation. Higher gradient numbers correspond to heavier fractions. siRNA content normalized to fraction 1 for each complex. 
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